Selling a Veterinary Specialty Hospital in 2026: Multiples, Named Buyers, and the Operator Playbook
Quick Answer
A US veterinary specialty hospital (24-hour ER + multi-specialty referral) in 2026 typically sells for roughly 10x to 18x EBITDA — among the highest multiples in healthcare-services M&A. Vet specialty is structurally premium because of high-acuity case mix, cash-pay revenue model (~70%+ cash, no insurance complexity), aging-pet-population demand, and durable customer relationships. By profile: a single-site mixed practice with limited ER ($1-3M EBITDA) goes 8x-11x; a dedicated single-site 24-hour ER ($2-5M EBITDA) goes 10x-13x; a single-site multi-specialty referral hospital ($3-8M EBITDA, surgery + internal medicine + emergency) goes 12x-15x; a mid-size multi-site specialty platform ($8-25M EBITDA) goes 13x-16x; a premium scale platform ($25M+ EBITDA, multi-state, comprehensive specialty + ER + boarding) reaches 15x-18x+. Active buyers include Mars Petcare Veterinary Health (Mars Inc. subsidiary, includes VCA Animal Hospitals ~1,000+ hospitals, BluePearl ~115+ specialty hospitals, Banfield Pet Hospital ~1,000+ clinics in PetSmart stores), Thrive Pet Healthcare (TSG Consumer Partners, ~400+ veterinary hospitals), National Veterinary Associates / NVA (KKR + Berkshire Partners, ~1,400+ hospitals globally), MedVet (PE-backed, multi-state specialty + ER), Veterinary Emergency Group / VEG (PE-backed, ER-only multi-site), Ethos Veterinary Health (Ethos Veterinary Hospitals + Compassion-First Pet Hospitals, multi-specialty), AmeriVet Veterinary Partners (PE-backed), Encore Vet Group (PE-backed), plus PE sponsors (KKR + Berkshire Partners, TSG Consumer Partners, Carlyle Group, Apax Partners, JAB Holding Company). The biggest multiple drivers are specialty mix (surgery, internal medicine, oncology, neurology, cardiology, emergency, dentistry, ophthalmology, dermatology), 24-hour ER coverage, cash-pay revenue model, modern operating system (Cornerstone, ezyVet, Provet, IDEXX Neo), referring DVM (rDVM) network strength, and board-certified specialist bench depth. Buyer-paid M&A advisory (CT Strategic Partners) costs the seller nothing.
If you own a US veterinary specialty hospital in 2026, the M&A market is structurally premium — multiples among the highest in any healthcare-services category (10x-18x EBITDA). Mars Petcare Veterinary Health dominates with VCA Animal Hospitals (~1,000+), BluePearl (~115+ specialty), and Banfield (~1,000+ PetSmart clinics). Thrive Pet Healthcare (TSG Consumer Partners), NVA (KKR + Berkshire Partners), MedVet, VEG, and Ethos Veterinary Health compete. PE sponsors continue aggressive consolidation.
What the asset is worth depends on three things: (1) specialty mix and 24-hour ER coverage (multi-specialty + ER is premium), (2) cash-pay revenue model (~70%+ cash, no insurance complexity), and (3) referring DVM network strength plus board-certified specialist bench. This guide covers real multiples by profile, the named buyers transacting, and the operator-level diligence buyers will run.
What this guide covers
- Vet specialty hospital multiples 2026: 8x-11x for mixed practice with limited ER, 10x-13x for dedicated 24-hour ER, 12x-15x for single-site multi-specialty, 13x-16x for mid-size multi-site, 15x-18x+ for premium scale. Among the highest multiples in healthcare-services M&A.
- Active buyers: Mars Petcare Veterinary Health (Mars Inc. subsidiary, VCA Animal Hospitals ~1,000+ + BluePearl ~115+ specialty + Banfield ~1,000+ PetSmart clinics), Thrive Pet Healthcare (TSG Consumer Partners, ~400+ hospitals), National Veterinary Associates / NVA (KKR + Berkshire Partners, ~1,400+ hospitals globally), MedVet (PE), Veterinary Emergency Group / VEG (PE, ER-only), Ethos Veterinary Health, AmeriVet Veterinary Partners (PE), Encore Vet Group (PE).
- PE sponsor activity: KKR + Berkshire Partners (NVA), TSG Consumer Partners (Thrive), Carlyle Group, Apax Partners, JAB Holding Company.
- Multiple drivers: specialty mix (surgery, internal medicine, oncology, neurology, cardiology, ER, dentistry, ophthalmology, dermatology), 24-hour ER coverage, cash-pay model (~70%+), modern operating system (Cornerstone, ezyVet, Provet, IDEXX Neo), referring DVM (rDVM) network strength, board-certified specialist bench depth.
- Things that compress: weak specialty mix, no 24-hour ER, weak rDVM relationships, owner-veterinarian dependence, weak operating system, single-state operations.
- Sellers pay nothing on CT Strategic Partners’ buyer-paid advisory.
Named M&A transactions (2021-2025)
| Target | Buyer | Year | What it tells us |
|---|---|---|---|
| Mars Petcare continued integration | Mars Inc. (private) | 2017-2025 | Mars acquired VCA in 2017 for $7.7B; continues integration with BluePearl + Banfield. |
| NVA expansion | KKR + Berkshire Partners | 2022-2025 | Major PE-backed vet platform crossed 1,400+ hospitals globally. |
| Thrive Pet Healthcare growth | TSG Consumer Partners | 2022-2025 | PE-backed multi-state vet platform continues expansion to ~400+ hospitals. |
| MedVet specialty expansion | PE-backed | 2022-2025 | Specialty + ER vet platform continues regional rollups. |
| VEG (Veterinary Emergency Group) growth | PE-backed | 2022-2025 | ER-only multi-site platform continues aggressive expansion. |
| Ethos Veterinary Health continued integration | PE-backed | 2022-2025 | Multi-specialty vet platform continues consolidation post Compassion-First merger. |
The named buyer landscape
Mars Petcare Veterinary Health (the dominant US vet platform)
- VCA Animal Hospitals — ~1,000+ general practice + multi-specialty hospitals.
- BluePearl — ~115+ veterinary specialty + emergency hospitals.
- Banfield Pet Hospital — ~1,000+ clinics in PetSmart stores (general practice focus).
- All three operate under Mars Petcare Veterinary Health, the subsidiary of Mars Inc.
Major PE-backed national platforms
- National Veterinary Associates / NVA (KKR + Berkshire Partners) — ~1,400+ hospitals globally.
- Thrive Pet Healthcare (TSG Consumer Partners) — ~400+ hospitals.
- Ethos Veterinary Health (formerly Compassion-First Pet Hospitals) — ~130+ hospitals.
- MedVet (PE-backed) — specialty + ER focus, ~40+ specialty hospitals.
- Veterinary Emergency Group / VEG (PE-backed) — ER-only multi-site, ~60+ ER hospitals.
- AmeriVet Veterinary Partners (PE-backed).
- Encore Vet Group (PE-backed).
PE sponsors active in this space
- KKR + Berkshire Partners (NVA), TSG Consumer Partners (Thrive Pet Healthcare), Carlyle Group, Apax Partners, JAB Holding Company, plus multiple consumer/healthcare PE funds.
What each buyer will pay for vs. what they reject
- Will pay premium for: multi-specialty referral capability (surgery, internal medicine, oncology, neurology, cardiology, ophthalmology, dermatology, dentistry), 24-hour ER coverage, cash-pay revenue model (~70%+ cash, minimal pet-insurance friction), board-certified specialist bench (DACVS surgery, DACVIM internal medicine, DACVO ophthalmology, etc.), strong referring DVM (rDVM) network, modern operating system (Cornerstone, ezyVet, Provet Cloud, IDEXX Neo, IDEXX MyVMA), real-estate optionality.
- Will compress or reject: general-practice-only without specialty mix, no 24-hour ER, owner-veterinarian dependence (single-DVM dependence), weak rDVM relationships, weak specialist bench, legacy operating system, weak emergency triage protocols.
The operator-level KPI playbook buyers will diligence
Specialty and case mix
- Specialty mix: Surgery, internal medicine, oncology, neurology, cardiology, ophthalmology, dermatology, dentistry, behavior, theriogenology.
- 24-hour ER coverage.
- Surgical case volume.
- Average revenue per case by specialty.
Revenue model
- Cash-pay percentage: 70%+ benchmark (no insurance complexity).
- Pet insurance percentage: Growing (~3-5% currently, projected higher).
- CareCredit / financing percentage.
- Wellness plan revenue.
Referring DVM (rDVM) network
- Active rDVM count.
- Referral volume by rDVM.
- rDVM concentration (no single rDVM above 5%).
- rDVM portal and communication infrastructure.
Provider bench
- Board-certified specialist count by specialty (DACVS, DACVIM, DACVO, DACVD, ACVECC, etc.).
- Emergency-trained veterinarian count.
- Veterinary technician count and certifications (RVT, LVT, CVT).
- Provider compensation model.
- Equity-rollover expectations (vet specialty deals typically 20-40% rollover).
Operating system
- Practice management software: Cornerstone (the operator standard), ezyVet, Provet Cloud, IDEXX Neo, IDEXX MyVMA, AVImark.
- Lab/imaging integration: IDEXX, Antech, Heska.
- Online client portal and digital communication.
Dangers and traps
1. General-practice-only without specialty mix
Compresses to general-vet multiples (4x-7x EBITDA) vs. specialty (10x-18x).
2. No 24-hour ER
24-hour ER coverage is the major multiple-builder for specialty hospitals.
3. Owner-veterinarian dependence
Single-DVM dependence compresses materially; build the specialist bench.
4. Weak rDVM network
Referring DVM relationships are the patient pipeline.
5. Weak specialist bench
Board-certified specialists are scarce and the multiple-driver.
6. Legacy operating system
Cornerstone, ezyVet, Provet Cloud, IDEXX are operator-standard.
7. Real-estate quality
Hospital infrastructure age and capex history matter.
8. Emergency triage protocols
Weak ER protocols compress; emergency revenue is high-margin.
Our POV in 2026
Veterinary specialty hospital M&A is one of the highest-multiple healthcare-services categories (10x-18x EBITDA) driven by cash-pay revenue model, aging-pet demand, and specialty premium. Mars Petcare Veterinary Health (VCA + Banfield + BluePearl) dominates. NVA (KKR + Berkshire Partners), Thrive Pet Healthcare (TSG Consumer Partners), Ethos, MedVet, and VEG compete. PE sponsors continue aggressive consolidation.
The right time to prepare is 12-18 months before going to market — build specialty mix, ensure 24-hour ER coverage, develop rDVM network, modernize operating system, build specialist bench.
Preparing your business for sale: 12-18 months out
- Get multi-year audited financials.
- Build specialty mix (surgery, internal medicine, oncology, neurology, cardiology).
- Ensure 24-hour ER coverage if not present.
- Develop rDVM network and referral infrastructure.
- Modernize operating system (Cornerstone, ezyVet, Provet Cloud, IDEXX).
- Build board-certified specialist bench.
- Document cash-pay and CareCredit revenue mix.
- Document add-backs.
- Run a competitive process. Mars Petcare Veterinary Health (VCA + BluePearl + Banfield), National Veterinary Associates / NVA (KKR + Berkshire Partners), Thrive Pet Healthcare (TSG Consumer Partners), Ethos Veterinary Health, MedVet, Veterinary Emergency Group / VEG, AmeriVet Veterinary Partners, Encore Vet Group, plus PE sponsors directly.
About the Author
Christoph Totter is the founder of CT Acquisitions, a buy-side partner headquartered in Sheridan, Wyoming. We work directly with 76+ buyers, search funders, family offices, lower middle-market PE, and strategic consolidators, including direct mandates with the largest home services consolidators that other intermediaries can’t access. The buyers pay us when a deal closes, not the seller. No retainer, no exclusivity, no contract until close. Connect on LinkedIn · Get in touch
Free, No Email Required
Get a personalized valuation in 90 seconds
Answer six quick questions and we’ll give you a sector-adjusted EBITDA multiple range plus the specific factors driving your number up or down.
Open the Valuation Tool →The five pillars of how CT Acquisitions works
Buyer pays our fee. Founders never write a check.
No engagement letter. No upfront cost. No exclusivity contract.
Search funders, family offices, lower-middle-market PE, strategics.
Confidential introductions to the right buyers. No bidding war.
Not 9-12 months. Not 18 months. Months, not years.
No Pitch · No Pressure
Ready to start a confidential conversation?
Tell us about your business. We’ll tell you what it’s likely worth, whether we have qualified buyers in our network, and what the next 60-120 days could look like. No engagement letter. No retainer. Walk at any time.
Start a Confidential Conversation →Frequently asked questions
What is the typical multiple for a veterinary specialty hospital in 2026?
Mixed practices with limited ER ($1-3M EBITDA) typically sell at 8x-11x EBITDA. Dedicated 24-hour ER hospitals ($2-5M EBITDA) go 10x-13x. Single-site multi-specialty referral hospitals ($3-8M EBITDA, surgery + internal medicine + emergency) go 12x-15x. Mid-size multi-site specialty platforms ($8-25M EBITDA) go 13x-16x. Premium scale platforms ($25M+ EBITDA, multi-state, comprehensive specialty + ER + boarding) reach 15x-18x+. These are among the highest multiples in healthcare-services M&A.
Who are the active buyers of veterinary specialty hospitals right now?
Mars Petcare Veterinary Health (Mars Inc. subsidiary, includes VCA Animal Hospitals ~1,000+ general/specialty, BluePearl ~115+ specialty, Banfield ~1,000+ PetSmart clinics, total ~2,100+ hospitals/clinics; the dominant US vet platform). PE-backed: National Veterinary Associates / NVA (KKR + Berkshire Partners, ~1,400+ hospitals globally), Thrive Pet Healthcare (TSG Consumer Partners, ~400+), Ethos Veterinary Health (~130+), MedVet (specialty + ER focus, ~40+ specialty hospitals), Veterinary Emergency Group / VEG (ER-only, ~60+), AmeriVet Veterinary Partners, Encore Vet Group. PE sponsors: KKR + Berkshire Partners, TSG Consumer Partners, Carlyle Group, Apax Partners, JAB Holding Company.
What hurts a veterinary specialty hospital’s valuation most?
General-practice-only without specialty mix (compresses to general-vet multiples), no 24-hour ER coverage (the major specialty multiple-builder), owner-veterinarian dependence with weak specialist bench, weak referring DVM (rDVM) network, legacy operating system, weak emergency triage protocols, single-state operations, and real-estate quality issues.
Why are veterinary specialty multiples so high?
Vet specialty hospitals have unusually attractive economics: cash-pay revenue model (~70%+ cash, minimal insurance complexity), aging-pet-population structural demand, scarce board-certified specialist bench creating supply constraint, 24-hour ER coverage with high-margin emergency cases, and durable referring DVM network relationships. The combination drives 10x-18x EBITDA multiples vs. 4x-7x for general veterinary practices.
Do I have to pay a broker fee?
No. CT Strategic Partners runs a buyer-paid M&A advisory model. The seller pays nothing.
How long does it take to sell a veterinary specialty hospital?
Typical process 5-9 months. Real-estate diligence extends timing. Add 12-18 months of preparation.
What is the typical equity rollover in a vet specialty MSO transaction?
Vet specialty deals typically include 20-40% equity rollover for selling veterinarians.
When should I start preparing if I plan to sell in 2027 or 2028?
12-18 months before going to market. Highest-leverage work: build specialty mix, ensure 24-hour ER coverage, develop rDVM network, modernize operating system, build board-certified specialist bench.
Related research
- How to sell a veterinary practice (general)
- How to sell a MedSpa
- How to sell a dermatology practice
- How to sell an ophthalmology practice
- How to sell an urgent care center
- How to sell an imaging center
- How to sell a clinical laboratory
- Healthcare business valuation
- Which industries is PE buying most in 2026
- Business broker alternative